Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 325
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04431687 | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393) | ||
| NCT01246193 | CKD-828(80/2.5mg) Pharmacokinetic Study | ||
| NCT06492655 | To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers | ||
| NCT02156544 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT02631954 | Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers | ||
| NCT02651753 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT02588937 | Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients | ||
| NCT06758661 | Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers | ||
| NCT07304700 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT03210649 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT02064621 | CKD-330 Drug-Drug Interaction Study (Candesartan) | ||
| NCT01743287 | The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee | ||
| NCT03233932 | CKD-841 Pharmacokinetic/Pharmacodynamic Study | ||
| NCT02480465 | Efficacy and Safety of Lobeglitazone Versus Sitagliptin | ||
| NCT02422030 | CKD-337(2) Drug-drug Interaction Study | ||
| NCT06627322 | A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | ||
| NCT04083872 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) | ||
| NCT03444402 | A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects | ||
| NCT05041790 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment | ||
| NCT04673682 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 | ||
| NCT01352689 | CKD-828(80/2.5mg) Pharmacokinetic Study_2nd | ||
| NCT04768673 | A Study to Investigate the PK and Safety of CKD-393 | ||
| NCT03246880 | Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients | ||
| NCT05526703 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy | ||
| NCT01663038 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination | ||
| NCT01682564 | To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure | ||
| NCT04805606 | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT07304726 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers | ||
| NCT06088017 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2) | ||
| NCT07258745 | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants | ||
| NCT04478097 | Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT06386328 | A Clinical Trial to Evaluate the Food Effect of CKD-378 | ||
| NCT01983735 | Efficacy and Safety of TELMINUVO to Stage 2 Hypertension | ||
| NCT04255589 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT04511000 | Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg | ||
| NCT06643819 | Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | ||
| NCT01580371 | Safety and Pharmacokinetic Profile of CKD-581 | ||
| NCT06695598 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers | ||
| NCT02005757 | Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT04555434 | Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH | ||
| NCT06709807 | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers | ||
| NCT03887871 | Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal | ||
| NCT01766505 | The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR) | ||
| NCT02526875 | Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled |
